Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

als, Inc. and Alkermes, Inc., submitted a reply to a complete response letter issued in October 2010 by FDA regarding Bydureon™, an investigational medication for type 2 diabetes. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date of January 28, 2012.
  • The company submitted its reply to a complete response letter by FDA regarding Amyvid™, a molecular Positron Emission Tomography (PET) imaging agent under investigation for the detection of beta-amyloid plaque in the brains of living patients.

  • The America Invents Act was signed into law, aligning new U.S. patent laws more closely with those from other countries and improving the global competiveness of U.S. innovator companies such as Lilly. The law will provide new advantages for U.S. inventors by streamlining the application process and addressing the backlog of current applications. This new law, which transitions the U.S. from a "first-to-invent" to a "first-inventor-to-file" system, is the most significant overhaul of the U.S. patent system in 175 years.

  • Third-Quarter Reported Results

    In the third quarter of 2011, worldwide total revenue was $6.148 billion, an increase of 9 percent compared with the third quarter of 2010. This 9 percent revenue growth was comprised of increases of 4 percent in volume and 4 percent due to the impact of foreign exchange rates. Price had a negligible impact on revenue growth, reflecting the loss of U.S. patent exclusivity for Gemzar® in November 2010. Total revenue in the U.S. increased 4 percent to $3.273 billion due to higher prices and increased volume. Total revenue outside the U.S. increased 15 percent to $2.874 billion due to the positive impact of foreign exchange rates and increased volume. Third-quarter 2011 total revenue was reduced by approximately $130 million due to the impact of U.S. health care reform.

    Gross margin increased 3.1 percent to $4.810 billion in the third quarte
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Lilly Declares Fourth-Quarter 2011 Dividend
    2. Lilly Announces Changes in Senior Management
    3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
    4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
    5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
    6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
    7. Lilly Health Channel Debuts on YouTube
    8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
    9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
    10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
    11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/21/2014)... 21, 2014  CASI Pharmaceuticals, Inc. (Nasdaq: ... the treatment of cancer and other diseases, announced today ... Administration (CFDA) has approved the Company,s application to conduct ... (TNBC) patients in China for ... Ken K. Ren , Ph.D., CASI,s Chief Executive Officer, ...
    (Date:7/21/2014)... , July 22, 2014 Research and ... of the "Global Coronary Stents Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 A coronary stent is a ... of stainless steel, cobalt-based alloy with mechanism of ... blockages that may occur in patients after they ...
    (Date:7/18/2014)... July 18, 2014  Patient engagement is a ... marketing is one of the principal groups that ... Policy groups within the pharmaceutical industry are among ... activities and initiatives to positively impact the "patient ... firm, Best Practices, LLC, identified the key support ...
    Breaking Medicine Technology:CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 2CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 3CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 4Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo 2Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo 3Government Affairs & Public Policy Groups Playing Critical Role in Patient Engagement, Reports Best Practices, LLC 2
    ... Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and ... Sachs Global Healthcare Conference on Tuesday, June 15 , at ... Los Angeles .  The presentation will be webcast on the following ... , ...
    ... Epocal, Inc., a leading edge provider of point ... Food and Drug Administration (FDA) clearance to market its new ... from the epoc System are used to evaluate acid-base status ... acidity of the blood).  The addition of lactate to the ...
    Cached Medicine Technology:Epocal Announces FDA Clearance of Lactate Test 2
    (Date:7/21/2014)... 22, 2014 Recently, Stwd.co.uk, a popular supplier ... wedding dresses. Additionally, the company’s chief executive officer has stated ... prices, up to 58% off. , “All our new and ... offer is launched to bring huge benefits to worldwide customers. ... cheap wedding outfits. By the way, we offer custom made ...
    (Date:7/21/2014)... PowerObjects, a professional services firm 100% ... for Microsoft Dynamics CRM, has joined the prestigious ... of the most strategic Microsoft Dynamics partners from ... them in the highest echelon of the Microsoft ... Microsoft Dynamics Inner Circle have performed to a ...
    (Date:7/21/2014)... (Philadelphia, PA) Patients who have a clot ... be treated with traditional blood-thinning medication or undergo ... comfortable that there is no difference in death ... more bleeding risks with the catheter procedure, according ... Medicine researchers. The study involved a review of ...
    (Date:7/21/2014)... July 21, 2014 (HealthDay News) -- The "viral reservoir" ... detection and elimination, is established much earlier than previously ... new obstacles for those working to eradicate the AIDS-causing ... HIV Research Program. They said the presence of the ... a cure for a subtype of HIV, known as ...
    (Date:7/21/2014)... (PRWEB) July 21, 2014 Western ... “Great College to Work For” by the Chronicle ... and also made the Honor Roll for the ... categories: Collaborative Governance, Compensation and Benefits, Confidence in ... Respect & Appreciation. , “Western University of Health ...
    Breaking Medicine News(10 mins):Health News:2014 Cheap Wedding Dresses, Newest Items Offered by Professional Company Stwd.co.uk 2Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2Health News:Temple study compares deep vein thrombosis therapies 2Health News:Temple study compares deep vein thrombosis therapies 3Health News:Temple study compares deep vein thrombosis therapies 4Health News:Animal Experiments Shed Light on HIV's Ability to Hide 2Health News:Western University of Health Sciences Elevated to “Great College to Work For” Honor Roll 2
    ... the experts are happy about the significant improvement in ... discovery of a new virus carried by bats ... ,Health and veterinary experts have singled out Indonesia, ... bird flu contagion is particularly worrisome. ,FAO's ...
    ... that a proud person could either be truly self-confident ... California study demonstrated that people have a propensity to ... authors term authentic pride, or they link it to ... ,While authentic pride was connected to more positive personality ...
    ... technique, called coherent anti-Stokes Raman cattering ... sclerosis. ,The researchers have studied ... the technique. ,Myelin is the fatty sheath coating ... efficient nerve fibre conduction. In diseases such as multiple sclerosis, ...
    ... there's one person who's still not convinced that Britney Spears is ... her soon to be ex-hubby Kevin Federline. ,A ... Britney is 'mentally unstable', and the reason behind her breakdown earlier ... ,"He thinks she's mentally unstable and too young to ...
    ... correction for clubfoot, a birth defect in which the foot ... compliance and fewer complications than the traditional brace used to ... professor of orthopedic surgery at the School of Medicine, designed ... active movement, preserve muscle strength in the foot and ankle ...
    ... cell startlingly similar to its human counterpart will likely ... organ tissue in people, two studies reported Wednesday. ... the inner-most layer of week-old rodent embryos, will provide ... diseases and injuries, the researchers said. ,"They ...
    Cached Medicine News:Health News:Avian Flu Seen in Others Birds too 2Health News:Avian Flu Seen in Others Birds too 3Health News:Pride, Even the Hubristic Kind, Allows Us to Survive 2Health News:New Innovation in Clubfoot Treatment 2Health News:New Innovation in Clubfoot Treatment 3Health News:'Missing Link' Stem Cells may Shorten Path to Therapies 2Health News:'Missing Link' Stem Cells may Shorten Path to Therapies 3
    Each handle is designed to fit a specific trephine size....
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size....
    Medicine Products: